Inotuzumab - CAS 1660159-36-3

Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

ADC Antibody, Immunology/Inflammation related, Apoptosis

Antibody-drug Conjugate/ADC Related, Immunology/Inflammation, Apoptosis

1660120

>95%

-20°C

Ice Packs

Inhibitory Antibodies